Mean time to cancer-specific death of apparently clinically localized prostate cancer: policy implications for threshold ages in prostate-specific antigen screening and ablative therapy-Reference-Cited by-同舟云学术

Mean time to cancer-specific death of apparently clinically localized prostate cancer: policy implications for threshold ages in prostate-specific antigen screening and ablative therapy

Published:2000-09 Issue:9 Volume:85 Page:1063-1066
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Horan A.H.,McGehee M.

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1464-410x.2000.00658.x/fullpdf

Reference19 articles.

1. IUCC. International Union Against Cancer 1979 :235

2. Implications of cell kinetic changes during the progression of human prostatic cancer;Berges;Clin Cancer Res,1995

3. Impact of tumor doubling time and age-based reference value for PSA on prostate cancer screening outcome;Stenman;J Urol,1995

4. Do results of radical prostatectomy for PSA detected cancer (T1c) support PSA screening?;Slezak;J Urol,1999

5. Wilt T Brawer MK Wheeler T Weiss DG. 1998

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate cancer screening among elderly men in Brazil: should we diagnose or not?;International braz j urol;2020-02

2. The Update of Active Surveillance Around the World: Utilization and Outcomes;Active Surveillance for Localized Prostate Cancer;2017-09-30

3. Patología prostática;FMC - Formación Médica Continuada en Atención Primaria;2017-04

4. Prostatakarzinom;Uroonkologie;2014

5. PSA Quo Vadis? It Is Reasonable to Start with Prostate-Specific Antigen Testing at the Age of 40!;Cancer Epidemiology Biomarkers & Prevention;2011-03-29